Skip to content

KROSKEROS THERAPEUTICS INC

CUSIP 492327101 · common stock

1 tracked investor held KEROS THERAPEUTICS INC (KROS) at the end of Q3 2026, worth $2.7M. The largest holder was Adar1 Capital Management, with 0.1% of its portfolio.

Holders · Q3 2026
1
New holders
0
Value held
$2.7M
Quarter-end price (est.)
$11.40

Investors holding KROS · Q3 2026

InvestorWeightSharesValueChange
Adar1 Capital Management
ADAR1 Capital Management, LLC
0.12%239,194$2.7MREDUCE-3.1%

History

QuarterHoldersNewSold outValue heldQuarter-end price (est.)
Q3 2026100$2.7M$11.40
Q2 2026100$2.6M$10.70
Q1 2026100$1.1M$11.04
Q4 2025100$383.8K$20.36